Michael K. Schultz

Chief Tech/Sci/R&D Officer at PERSPECTIVE THERAPEUTICS, INC.

Consumer Services

Commercial Services

Health Technology

Profile

Michael K.
Schultz founded Viewpoint Molecular Targeting, Inc. in 2008, where he is working as Chief Science Officer from 2013.
Dr. Schultz also currently works at Perspective Therapeutics, Inc., as Chief Science Officer.
Dr. Schultz also formerly worked at the University of Iowa, as Associate Professor and National Institute of Health Policy, as Principal.

Michael K. Schultz active positions

Companies	Position	Start
PERSPECTIVE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-
Viewpoint Molecular Targeting, Inc. Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.	Founder	2007-12-31

All active positions of Michael K. Schultz

Former positions of Michael K. Schultz

Companies	Position	End
National Institute of Health Policy	Corporate Officer/Principal	-
University of Iowa	Corporate Officer/Principal	-

See the detail of Michael K. Schultz's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael K. Schultz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
PERSPECTIVE THERAPEUTICS, INC.	Health Technology

Private companies	2
National Institute of Health Policy
Viewpoint Molecular Targeting, Inc. Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.	Commercial Services